Pages that link to "Q40218001"

The following pages link to siRNA-resistance in treated HCV replicon cells is correlated with the development of specific HCV mutations (Q40218001):

Displaying 23 items.

• VIRsiRNAdb: a curated database of experimentally validated viral siRNA/shRNA (Q24621942) (← links)
• Combinations of siRNAs against La Autoantigen with NS5B or hVAP-A Have Additive Effect on Inhibition of HCV Replication (Q27469011) (← links)
• RNAi Targeting of West Nile Virus in Mosquito Midguts Promotes Virus Diversification (Q27488775) (← links)
• Combination of small interfering RNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cells (Q27489094) (← links)
• Small interfering RNA targeting m2 gene induces effective and long term inhibition of influenza A virus replication. (Q33455759) (← links)
• Expression of plasmid-based shRNA against the E1 and nsP1 genes effectively silenced Chikungunya virus replication (Q34441412) (← links)
• Possibilities for RNA interference in developing hepatitis C virus therapeutics (Q35261143) (← links)
• Evaluation of canonical siRNA and Dicer substrate RNA for inhibition of hepatitis C virus genome replication--a comparative study (Q35565539) (← links)
• Adapted Resistance to the Knockdown Effect of shRNA-Derived Srsf3 siRNAs in Mouse Littermates (Q36090985) (← links)
• Inhibition of hepatitis C virus replication by intracellular delivery of multiple siRNAs by nanosomes (Q36220684) (← links)
• Potential role of RNAi in the treatment of HCV infection (Q36960064) (← links)
• Inhibition of hepatitis B virus gene expression and replication by artificial microRNA (Q37335122) (← links)
• Prospects of RNAi and microRNA-based therapies for hepatitis C. (Q37489877) (← links)
• The role of innate immunity in conditioning mosquito susceptibility to West Nile virus (Q37666784) (← links)
• In vivo therapeutic potential of Dicer-hunting siRNAs targeting infectious hepatitis C virus. (Q37718105) (← links)
• AAV-mediated gene therapy for liver diseases: the prime candidate for clinical application? (Q37825907) (← links)
• Leveraging Therapeutic Potential of Multi-Targeted Sirna Inhibitors (Q37855818) (← links)
• Effect of siRNA pre-Exposure on Subsequent Response to siRNA Therapy (Q38858347) (← links)
• In vitro inhibition of CSFV replication by multiple siRNA expression (Q39519335) (← links)
• RNA interference against hepatitis B virus with endoribonuclease-prepared siRNA despite of the target sequence variations (Q40151467) (← links)
• RNA Interference against Animal Viruses: How Morbilliviruses Generate Extended Diversity To Escape Small Interfering RNA Control (Q40319585) (← links)
• Inhibition of hepatitis C virus using siRNA targeted to the virus and Hsp90. (Q40446960) (← links)
• siRNA combinations mediate greater suppression of hepatitis B virus replication in mice (Q42236371) (← links)